CSIMarket



Alaunos Therapeutics Inc.  (TCRT)
Other Ticker:  
 

Cumulative Alaunos Therapeutics's Long Term Debt to Equity for Trailing Twelve Months Period

TCRT's Long Term Debt to Equity for Trailing Twelve Months Period and Long Term Debt, Equity growth


Select the Comparisons : Select the Ratio:

TCRT Long Term Debt to Equity for Trailing Twelve Months Period

(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
(Jun 30 2021)
II. Quarter
Y / Y Equity Growth -54.49 % -53.5 % -59.94 % -57.96 % -51.05 %
Y / Y Long Term Debt Growth - - - - -
Long Term Debt to Equity for Trailing Twelve Months Period 0.2 0.15 0.09 0.03 -
Total Ranking # # # # #
Seq. Equity Growth -18.2 % -15.39 % -15.5 % -22.17 % -16.43 %
Seq. Long Term Debt Growth -56.68 % -36.47 % 33.48 % - -


Long Term Debt to Equity for Trailing Twelve Months Period Comment
On the trailing twelve months basis Despite long-term debt repayement of -56.68% in II. Quarter, Long Term Debt to Equity for Trailing Twelve Months Period improved to 0.2, above Alaunos Therapeutics's average Long Term Debt to Equity for Trailing Twelve Months Period.
Long Term Debt to Equity for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Major Pharmaceutical Preparations industry Alaunos Therapeutics Inc. achieved lowest Long Term Debt to Equity for Trailing Twelve Months Period. While total ranking remained unchanged compare to previous quarter at no. .

What is Long Term Debt to Equity Ratio?
What is TCRT selling?
Long Term Debt to Equity TCRT in the most recent quarter
Long Term Debt to Equity for Trailing Twelve Months Period Company Ranking
Within: No.
Industry #
Sector #
S&P 500 # 0


Long Term Debt to Equity for Trailing Twelve Months Period Statistics
High Average Low
0 0 0
 




Companies with similar average Long Term Debt to Equity for Trailing Twelve Months Period for 12 months ending Jun 30 2022, within Major Pharmaceutical Preparations Industry Long Term Debt to Equity for Trailing Twelve Months Period
Biodelivery Sciences International Inc   0.54 
Abbott Laboratories  0.49 
Akebia Therapeutics Inc.  0.49 
Syros Pharmaceuticals inc.  0.46 
Journey Medical Corporation  0.46 
Evolus Inc.  0.45 
Pfizer Inc  0.45 
China Pharma Holdings Inc.  0.44 
Novan Inc.  0.43 
Johnson and Johnson  0.40 
Cumberland Pharmaceuticals Inc.  0.39 
Cytokinetics Incorporated  0.38 
Eton Pharmaceuticals Inc.  0.38 
Tempest Therapeutics Inc.  0.37 
Fortress Biotech Inc.  0.37 
Durect Corp  0.37 
Seres Therapeutics Inc.  0.36 
Supernus Pharmaceuticals inc.  0.35 
Trevi Therapeutics inc.  0.35 
Medavail Holdings Inc.  0.34 
Skye Bioscience Inc.  0.33 
Geron Corp  0.29 
Otonomy Inc.  0.29 
Corbus Pharmaceuticals Holdings Inc.  0.28 
Alkermes Plc.  0.27 
Organogenesis Holdings Inc.  0.27 
Ligand Pharmaceuticals Incorporated  0.25 
Kamada Ltd  0.25 
Biomarin Pharmaceutical Inc  0.25 
Panbela Therapeutics Inc.  0.25 


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

MCG's Profile

Stock Price

MCG's Financials

Business Description

Fundamentals

Charts & Quotes

MCG's News

Suppliers

MCG's Competitors

Customers & Markets

Economic Indicators

MCG's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071